Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A benzopyran with antiarrhythmic activity is an inhibitor of Kir3.1-containing potassium channels

Journal of Biological Chemistry(2021)10.1016/j.jbc.2021.100535Source: DataRank Database

A benzopyran with antiarrhythmic activity is an inhibitor of Kir3.1-containing potassium channels is a research paper published in Journal of Biological Chemistry (2021). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: goldTopics (29)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Yaser Alhamshari,Lucas Cantwell,Said EI-Haou,Giasemi C. Eptaminitaki ORCID,Mengmeng Chang ORCID

Live enrichment

PubMed:33713702 PMC:PMC8086025

NHLBI NIH HHS

Grant: R01 HL129136

NHLBI NIH HHS

Grant: R21 HL138064

NHLBI NIH HHS

Grant: R01 HL059949

NHLBI NIH HHS

Grant: R01 HL144615

National Institutes of Health

Grant: 7R01HL129136-02

Molecular Mechanisms for Atrial Fibrillation in Aging

National Institutes of Health

Grant: 5R01HL059949-07

Structural Determinants of PIP2 Regulation

National Institutes of Health

Grant: 1R21HL138064-01

Bioengineered peptibodies as antiarrhythmic therapy in atrial fibrillation

goldLicense: cc-by

publisherhttps://doi.org/10.1016/j.jbc.2021.100535

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8086025

Unpaywallhttp://www.jbc.org/article/S0021925821003136/pdf

Europe_PMChttps://europepmc.org/articles/PMC8086025

Europe_PMChttps://europepmc.org/articles/PMC8086025?pdf=render

Fields of Study

0301 basic medicine03 medical and health sciences0302 clinical medicine

MeSH Terms

AnimalsHumansMiceAtrial FibrillationBenzopyransAnti-Arrhythmia AgentsIon Channel GatingAction PotentialsG Protein-Coupled Inwardly-Rectifying Potassium ChannelsMolecular Docking Simulation

Keywords

Ion channelHomology modelingMolecular dockingMolecular dynamicsInhibition MechanismAction PotentialsMolecular Docking SimulationMiceG Protein-Coupled Inwardly-Rectifying Potassium ChannelsAtrial FibrillationAnimalsHumansBenzopyransAnti-Arrhythmia AgentsIon Channel GatingResearch Article

Sustainable Development Goals

SDG 3: 3. Good health

A benzopyran with antiarrhythmic activity is an inhibitor of Kir3.1-containing potassium channels

FAIR Checklist

Authors (15)

Funding (7 grants)

Open Access

Topics

Annotations (Europe PMC)